Name: UMIN ID:
Unique ID issued by UMIN | UMIN000029605 |
---|---|
Receipt number | R000033813 |
Scientific Title | Phase2, single arm investigator initiated study of Atezolizumab in advanced or recurrent non-small cell lung cancer patients for biomarker research |
Date of disclosure of the study information | 2017/11/01 |
Last modified on | 2020/08/12 13:31:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/10/18 09:02:59 | ||
2 | Update | 2017/12/05 14:29:01 | Recruitment status Anticipated trial start date |
|
3 | Update | 2018/09/10 09:43:29 | Recruitment status |
|
4 | Update | 2020/08/12 13:27:36 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
5 | Update | 2020/08/12 13:31:45 | Recruitment status Date of IRB Last follow-up date |